| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/13/2011 | US20110008334 Nogo-a binding with enhanced affinity and pharmaceutical use thereof |
| 01/13/2011 | US20110008319 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/13/2011 | US20110008286 Novel proline substituted cyclosporin analogues |
| 01/13/2011 | US20110008285 Novel cyclosporin analogues |
| 01/13/2011 | US20110008284 Novel clyclosporin analogues |
| 01/12/2011 | EP2272868A2 Combination therapy for B cell disorders |
| 01/12/2011 | EP2272864A2 Binding agents which inhibit myostatin |
| 01/12/2011 | EP2272501A1 Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate |
| 01/12/2011 | EP2271665A1 Highly bridged peptides from actinomadura namibiensis |
| 01/12/2011 | EP2271356A1 Novel antimicrobial peptides |
| 01/12/2011 | EP2121922B1 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered |
| 01/12/2011 | EP1991586B1 Chimeric constructs between cancer-homing peptides and cell-penetrating peptides coupled to anticancer drugs and/or diagnostic agent/agents |
| 01/12/2011 | EP1866328B1 Peptides which increase collagen or hyaluronic acid production |
| 01/12/2011 | EP1639509B1 Protein crystal comprising the processivity clamp factor of dna polymerase and a ligand, and its uses |
| 01/12/2011 | EP1470224B1 Molecular libraries |
| 01/12/2011 | CN1943781B Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2011 | CN1894273B Peptide inhibiting angiotensin converting enzyme |
| 01/12/2011 | CN101946001A Polypeptide-nucleic acid conjugates and uses thereof |
| 01/12/2011 | CN101945888A Recovery of hydrophobic peptides from oils |
| 01/12/2011 | CN101945887A Cationic core-shell peptide nanoparticles |
| 01/12/2011 | CN101942011A Neutralizing epitope of human adenovirus type 3 (HAdV-3) and type 7 (HAdV-7) and application thereof |
| 01/12/2011 | CN101942010A Method for promoting solid phase synthesis of balsam pear MC-JJ0106 polypeptide analogue by microwaves and application thereof |
| 01/11/2011 | US7868135 In particular amphomycin or aspartocin derivatives, and compositions of such lipopeptides for use in treating or preventing, for example, primary infection sites, secondary infections arising from a primary disease state, or infections associated with foreign bodies |
| 01/11/2011 | US7868134 Immunogenic peptides derived from sclerostin |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/11/2011 | CA2205092C Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 01/06/2011 | WO2011003062A2 Probiotic compositions and processes thereof |
| 01/06/2011 | WO2011000848A1 Solid phase peptide synthesis of peptide alcohols |
| 01/06/2011 | WO2011000095A1 Multimeric peptide conjugates and uses thereof |
| 01/06/2011 | WO2010113035A3 Peptide-based beta turn mimetics |
| 01/06/2011 | WO2010096604A3 Uses of cancer-targeting peptides in cancer diagnosis |
| 01/06/2011 | WO2010091651A4 Novel antimicrobial peptides |
| 01/06/2011 | WO2009007849A3 Il-23 receptor antagonists and uses thereof |
| 01/06/2011 | US20110003756 C5a Receptor Antagonists |
| 01/06/2011 | US20110003753 COMPOSITIONS AND METHODS FOR DISRUPTING THE FUNCTION OF THE TRANSCRIPTIONAL REPRESSOR COMPONENT Sin3A-PAH2 DOMAIN TO INDUCE DIFFERENTIATION AND GROWTH INHIBITION IN BREAST CANCER |
| 01/06/2011 | US20110003752 New Blood Coagulation Factor Inhibitors |
| 01/06/2011 | US20110003385 Regulated transcription of targeted genes and other biological events |
| 01/06/2011 | US20110003362 Conjugates of biological substances |
| 01/06/2011 | US20110002954 Rhoc-based immunotherapy |
| 01/06/2011 | US20110002932 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF |
| 01/06/2011 | US20110002916 Plasmodium falciparum antigens and their vaccine and diagnostic applications |
| 01/06/2011 | US20110002914 Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/06/2011 | US20110002880 Material For Wound Healing and Skin Reconstruction |
| 01/06/2011 | US20110002848 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 01/06/2011 | CA2766537A1 Multimeric peptide conjugates and uses thereof |
| 01/05/2011 | EP2270192A1 Glycopeptide antibiotics |
| 01/05/2011 | EP2270144A1 Partial peptide of survivin presented on mhc class ii molecule and use thereof |
| 01/05/2011 | EP2270042A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270041A2 KDR peptides and vaccines comprising the same |
| 01/05/2011 | EP2270040A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 01/05/2011 | EP2270035A2 Peptides enhancing CEH activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis |
| 01/05/2011 | EP2270027A1 Polypeptides having brain-localizing activity and uses thereof |
| 01/05/2011 | EP2270025A1 Solid phase peptide synthesis of peptide alcohols |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2268667A2 Somatostatin receptor 2 antagonists |
| 01/05/2011 | EP2268658A1 Peptides and aptamers thereof as specific modulators of mutant p53 function |
| 01/05/2011 | EP2268657A2 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 01/05/2011 | EP2268609A1 Synthesis of a peg-6 moiety from commercial low-cost chemicals |
| 01/05/2011 | EP2016950B1 Pharmaceutical composition comprising an exendin-4 peptide |
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | CN101939329A Amino acid pairing-based self assembling peptides and methods |
| 01/05/2011 | CN101939328A Genes and proteins for the biosynthesis of the lantibiotic 107891 |
| 01/05/2011 | CN101935339A Solid-phase preparation method for buserelin |
| 01/05/2011 | CN101935338A Reticuloprotein epitope, anti-reticuloprotein antibody and application thereof |
| 01/05/2011 | CN101098884B Methods for the specific production of lysobactin fragments |
| 01/04/2011 | US7863417 which activate synthesis reactions in skin matrix by specifically stimulating growth factor TGF beta 1 responsible for anabolism of macromolecules therein; antiwrinkling |
| 01/04/2011 | US7863416 Hexapeptide of given formula; binds with opioid receptor and exhibits agonist and antagonist activity; anxiolytics, diuretics, and anti-cancer agents |
| 01/04/2011 | US7863415 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 01/04/2011 | US7863411 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection |
| 01/04/2011 | US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP) |
| 01/04/2011 | CA2573307C Use of platelet aggregation inhibitors |
| 01/04/2011 | CA2473973C Method of stimulating growth and resistance to diseases of aquatic organisms |
| 01/04/2011 | CA2419423C Conjugates of peptides and peptide mimetics having integrin inhibitor properties |
| 01/04/2011 | CA2381461C Lhrh antagonists having improved solubility properties |
| 01/04/2011 | CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 12/30/2010 | US20100331520 Metastin derivatives and use thereof |
| 12/30/2010 | US20100331519 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants |
| 12/30/2010 | US20100331263 Methods and compositions for inhibiting angiogenesis |
| 12/30/2010 | US20100331262 PEPTIDE VACCINE USING MIMIC MOLECULES OF AMYLOID Beta PEPTIDE |
| 12/30/2010 | US20100331260 Stabilized bitamin c derivatives having a peptide molecule, preparation method thereof, and composition containing the same |
| 12/30/2010 | US20100331239 Cd14 and peptides thereof for protection of cells against cell death |
| 12/30/2010 | US20100331236 Cyclic peptides as g-protein coupled receptor antagonists |
| 12/30/2010 | US20100331233 Crystal of xpa and ercc1 complex and uses thereof |
| 12/30/2010 | US20100330700 Substrate for assaying beta-glucan and/or endotoxin and assay method |
| 12/30/2010 | US20100330668 Interaction Between the VHL Tumour Suppressor and Hypoxia Inducible Factor, and Assay Methods Relating Thereto |
| 12/30/2010 | US20100330667 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/30/2010 | US20100330109 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 12/30/2010 | US20100330100 Pseudomonas aeruginosa-outer membrane protein pa4710 |
| 12/30/2010 | US20100330075 Monoclonal human tumor-specific antibody |
| 12/30/2010 | US20100330072 Myostatin binding agents |
| 12/30/2010 | US20100329985 Treatment and prevention of inflammatory diseases and autoimmune diseases |
| 12/30/2010 | US20100329983 Compounds and methods for the detection of trpv-6 cancers and drug delivery |
| 12/29/2010 | WO2010151495A2 Materials and methods for treating and preventing viral infections |
| 12/29/2010 | WO2010151126A1 Biologically produced cyclic affinity tags |
| 12/29/2010 | WO2010150730A1 Process for production of peptide thioester |
| 12/29/2010 | WO2010150708A1 Protein-modifying agent |
| 12/29/2010 | WO2010149016A1 New compound and use thereof |
| 12/29/2010 | WO2010148501A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery |
| 12/29/2010 | WO2010054108A9 Cas6 polypeptides and methods of use |
| 12/29/2010 | EP2267125A1 Cancer cell motility and cancer cell infiltration inhibitor |